20240041510. SEGMENTAL VASCULAR ABLATION simplified abstract (Crossfire Medical Inc)

From WikiPatents
Revision as of 11:09, 8 February 2024 by Wikipatents (talk | contribs) (Creating a new page)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

SEGMENTAL VASCULAR ABLATION

Organization Name

Crossfire Medical Inc

Inventor(s)

Adam Tschida of Brooklyn Park MN (US)

SEGMENTAL VASCULAR ABLATION - A simplified explanation of the abstract

This abstract first appeared for US patent application 20240041510 titled 'SEGMENTAL VASCULAR ABLATION

Simplified Explanation

The disclosed patent application describes a system for treating a vessel wall in a patient's vascular system. The system includes a controller and a sheath with an open proximal sheath end connected to the controller. The distal sheath end is designed for insertion into the patient's vascular system, and there is a working lumen that extends through the sheath.

Key points of the patent/innovation:

  • The system includes a wire that extends from the controller through the working lumen.
  • The distal end of the wire is configured to mechanically treat a vessel wall in a treatment segment.
  • The length of the distal wire end determines the length of the treatment segment.
  • The working lumen is designed to receive the wire and allow fluid to pass through for chemical treatment of the treatment segment.
  • The system can mechanically treat the vessel wall when it receives a first input and deliver fluid when it receives a second and/or third input.

Potential applications of this technology:

  • Treatment of vascular diseases such as atherosclerosis.
  • Minimally invasive procedures for removing plaque or blockages in blood vessels.
  • Targeted drug delivery to specific areas of the vascular system.

Problems solved by this technology:

  • Provides a more precise and controlled method for treating vessel walls.
  • Allows for both mechanical and chemical treatment of the treatment segment.
  • Minimizes the risk of damage to surrounding tissues.

Benefits of this technology:

  • Improved patient outcomes due to targeted and effective treatment.
  • Minimally invasive procedure reduces the need for open surgery.
  • Enhanced precision and control during the treatment process.


Original Abstract Submitted

the disclosure includes a controller and a sheath having an open proximal sheath end coupled to the controller, an open distal sheath end configured for insertion into a vascular system of a patient, and a working lumen extending through the sheath. the system may include a wire extending from the controller through the working lumen, the wire having a distal wire end configured to mechanically treat a vessel wall of a treatment segment, a length of the distal wire end defining a length of the treatment segment. the working lumen may be configured to slidably receive the wire and allow for a passage of a fluid about the wire therethrough to chemically treat the treatment segment. when the system receives a first input the distal wire end may mechanically treat the vessel wall. when the system receives a second input and/or a third input, the system may deliver the fluid.

Retrieved from "http://wikipatents.org/index.php?title=20240041510._SEGMENTAL_VASCULAR_ABLATION_simplified_abstract_(Crossfire_Medical_Inc)&oldid=32401"